Related Experiment Videos
A Bayesian model for evaluating specificity of treatment effects in clinical trials
R M Simon1, D O Dixon, B Freidlin
1Biometrics Research Branch, National Cancer Institute (NCI), Bethesda, MD 20892, USA.
Cancer Treatment and Research
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interim monitoring for non-inferiority trials: minimizing patient exposure to inferior therapies.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Assessing treatment efficacy in the subset of responders in a randomized clinical trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Evaluation of chemoresponse assays as predictive markers.
British journal of cancer·2015
Assessing causal relationships between treatments and clinical outcomes: always read the fine print.
Bone marrow transplantation·2011
Characterizing dye bias in microarray experiments.
Bioinformatics (Oxford, England)·2005
Robust TDT-type candidate-gene association tests.
Annals of human genetics·2002
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Genomic insights into pre-antibiotic osteomyelitis pathogens and their link to current resistant hospital strains.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026